Company Announces Plans to File for Conditional Marketing for Duchenne Muscular Dystrophy Drug in the EU

According to a story from Market Screener, the specialty pharmaceutical company Santhera Pharmaceuticals recently released an announcement in which the company revealed its intent to file for Conditional Marketing Authorization…

Continue Reading Company Announces Plans to File for Conditional Marketing for Duchenne Muscular Dystrophy Drug in the EU
Experimental Treatment for Sanfilippo Syndrome Type B Gets Fast Track Designation
PixLoger / Pixabay

Experimental Treatment for Sanfilippo Syndrome Type B Gets Fast Track Designation

According to a story from finanznachrichten.de, the biopharmaceutical company Abeona Therapeutics, Inc. recently announced that its experimental medical product ABO-101 has earned Fast Track designation from the US Food and…

Continue Reading Experimental Treatment for Sanfilippo Syndrome Type B Gets Fast Track Designation
Phase 3 Myelodysplastic Syndromes Trial Reaches Enrollment Milestone
DarkoStojanovic / Pixabay

Phase 3 Myelodysplastic Syndromes Trial Reaches Enrollment Milestone

According to a story from sectorpublishingintelligence.co.uk, the biopharmaceutical company Onconova Therapeutics, Inc. recently announced that they have successfully surpassed the 75 percent milestone for enrollment in the company's Phase 3…

Continue Reading Phase 3 Myelodysplastic Syndromes Trial Reaches Enrollment Milestone

Experimental Combination Treatment for Acute Myeloid Leukemia Shows Potential in Early Trial

According to a story from BioPortfolio, the biopharmaceutical company AVEO Pharmaceuticals and the lung cancer diagnostic company Biodesix recently released the results from the Phase Ib clinical trial testing a…

Continue Reading Experimental Combination Treatment for Acute Myeloid Leukemia Shows Potential in Early Trial
Experimental Therapy for T-Cell Prolymphocytic Leukemia Earns Orphan Drug Designation
DarkoStojanovic / Pixabay

Experimental Therapy for T-Cell Prolymphocytic Leukemia Earns Orphan Drug Designation

According to a story from Market Screener, the biopharmaceutical company Imbrium Therapeutics LP recently announced that the US Food and Drug Administration (FDA) has given Orphan Drug designation for the…

Continue Reading Experimental Therapy for T-Cell Prolymphocytic Leukemia Earns Orphan Drug Designation
Funding Goal Achieved for Pulmonary Arterial Hypertension Clinical Trial
jarmoluk / Pixabay

Funding Goal Achieved for Pulmonary Arterial Hypertension Clinical Trial

According to a story from Euroinvestor, the drug development company Resverlogix Corp. recently announced that it has received the necessary $2.9 million in funding for a Phase 2 clinical trial…

Continue Reading Funding Goal Achieved for Pulmonary Arterial Hypertension Clinical Trial
Study Reveals Combination Therapy for Aggressive, Cancerous Neuroendocrine Tumors
Bru-nO / Pixabay

Study Reveals Combination Therapy for Aggressive, Cancerous Neuroendocrine Tumors

According to a story from EurekAlert!, a recent research study has found that a two part immunotherapy combination treatment has the potential to be a useful treatment for high-grade neuroendocrine…

Continue Reading Study Reveals Combination Therapy for Aggressive, Cancerous Neuroendocrine Tumors
Korean Research Team Pioneers Method That Could Personalize Treatment for Glioblastoma
HeungSoon / Pixabay

Korean Research Team Pioneers Method That Could Personalize Treatment for Glioblastoma

According to a story from Korean Biomedical Review, a team of researchers from Seoul National University, headed by professor Paek Sun-ha, have developed an approach utilizing 3D cell printing technology…

Continue Reading Korean Research Team Pioneers Method That Could Personalize Treatment for Glioblastoma
The Department of Education’s 2020 Budget is Requesting Cuts to the Special Olympics and Special Education. What Does This Mean for Rare Patients?
Pexels / Pixabay

The Department of Education’s 2020 Budget is Requesting Cuts to the Special Olympics and Special Education. What Does This Mean for Rare Patients?

If you are an avid follower of the latest news, then you have probably heard about one the latest sensational headlines to come out of DC lately: the US Department…

Continue Reading The Department of Education’s 2020 Budget is Requesting Cuts to the Special Olympics and Special Education. What Does This Mean for Rare Patients?
Proof of Concept Results Achieved in Congenital Adrenal Hyperplasia Trial
DarkoStojanovic / Pixabay

Proof of Concept Results Achieved in Congenital Adrenal Hyperplasia Trial

According to a story from BioSpace, the biotechnology company Spruce Biosciences recently announced that they have achieved positive proof of concept data in the company's clinical trial. This is a…

Continue Reading Proof of Concept Results Achieved in Congenital Adrenal Hyperplasia Trial